Skip to main content
. 2013;6(2):48–62.

Table 3.

Indications for Considering the Use of Cell-Free Fetal DNA Analysis for Fetal Aneuploidy

  • Maternal age ≥ 35 years at delivery

  • Fetal ultrasonographic findings indicating an increased risk for aneuploidy

  • Personal or family history of a prior pregnancy with a trisomy

  • Positive test result for aneuploidy, including first trimester, sequential, or integrated screen, or a quadruple screen

  • Parental balanced Robertsonian translocation with increased risk for fetal trisomy 13 or trisomy 21

Data from Obstet Gynecol. 2012;120:1532—1534.93